Physician profile
Paul E Mullen
NPI 1114977451
$29,375.56
in general payments reported to CMS, 2019-2025
52 companies · $3,093 in 2025
The $3,093 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,543 · 2020: $1,255 · 2021: $2,708 · 2022: $4,949 · 2023: $6,595 · 2024: $4,233 · 2025: $3,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,529 · Travel and Lodging: $5,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,528.94 |
| Travel and Lodging | $5,392.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,279.97 | 2019-2025 | Aveir, Cardiomems, Merlin@Home |
| Medtronic Vascular, INC. | $3,376.39 | 2019 | |
| Boston Scientific Corporation | $3,030.43 | 2019-2025 | Versacross Access Solution, General - Structural Heart, Watchman Access System |
| Bard Peripheral Vascular, INC. | $2,016.76 | 2022-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Novartis Pharmaceuticals Corporation | $1,690.58 | 2019-2025 | Leqvio |
| Pfizer INC. | $1,280.95 | 2019-2025 | |
| Abiomed | $1,259.42 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,040.59 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $1,004.93 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $717.17 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $688.21 | 2021-2025 | Verquvo, Winrevair |
| Philips North America LLC | $684.15 | 2019-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided, Mcot |
| Amgen INC. | $559.89 | 2019-2025 | Repatha, Repatha |
| Endologix LLC | $513.47 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Actelion Pharmaceuticals US, INC. | $448.30 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $326.46 | 2021-2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $276.19 | 2021-2025 | |
| Chiesi USA, INC. | $256.65 | 2019-2023 | Kengreal |
| Esperion Therapeutics, INC. | $244.24 | 2020-2025 | Nexletol |
| Penumbra, INC. | $242.31 | 2024-2025 | Indigo System |
| Astrazeneca Pharmaceuticals Lp | $241.01 | 2020-2023 | Farxiga |
| Medtronic, INC. | $239.32 | 2021-2025 | Micra |
| Biotronik INC. | $229.12 | 2019-2025 | Acticor 7 Vr-T Dx |
| Lexicon Pharmaceuticals, INC. | $207.37 | 2024 | Inpefa |
| Heartflow, INC. | $194.58 | 2022-2024 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.78 | 2023-2025 | Lifevest |
| Novo Nordisk INC | $129.28 | 2024-2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $88.63 | 2019 | |
| Cvrx, INC. | $82.98 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $81.27 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $80.72 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $64.31 | 2019-2020 | |
| Gilead Sciences, INC. | $58.20 | 2019 | |
| Stryker Corporation | $56.31 | 2021-2024 | Axs Vecta 71 |
| Lundbeck LLC | $53.72 | 2019 | |
| Baxter Healthcare | $49.03 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Recor Medical INC | $47.17 | 2025 | Paradise Ultrasound Renal Denervation System |
| Ge Healthcare | $43.58 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $37.40 | 2019 | |
| Amarin Pharma, INC. | $31.58 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.17 | 2019-2020 | |
| Osprey Medical INC | $28.00 | 2019 | |
| Terumo Medical Corporation | $26.69 | 2020-2022 | |
| United Therapeutics Corporation | $25.58 | 2024 | |
| Silk Road Medical, INC. | $20.58 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.99 | 2024 | Arcalyst |
| Atricure, INC. | $18.94 | 2019 | |
| Inari Medical, INC. | $18.77 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $14.52 | 2021 | |
| Ekos Corporation | $14.44 | 2019 | |
| Scpharmaceuticals INC. | $13.96 | 2024 | |
| Cardiovascular Systems INC. | $2.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Mullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.